Neurocrine Biosciences, Inc.
Pharmaceutical Compositions Comprising an Antipsychotic Drug and a VMAT2 Inhibitor and Uses Thereof
Last updated:
Abstract:
New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
Status:
Application
Type:
Utility
Filling date:
16 Jan 2019
Issue date:
19 Dec 2019